ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC)-Reference-Cited by-同舟云学术

ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC)

Published:2019-03 Issue: Volume:141 Page:63-72
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Alves-Fernandes Débora Kristina^ORCID,Oliveira Érica Aparecida de,Faião-Flores Fernanda,Alicea-Rebecca Gretchen,Weeraratna Ashani T.,Smalley Keiran S.M.,Barros Silvia Berlanga de Moraes,Maria-Engler Silvya Stuchi

Funder

FAPESP

CNPq

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Pharmacology

Reference57 articles.

1. Melanoma: from mutation to medicine;Tsao;Genes Dev,2012

2. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;New Eng. J. Med,2010

3. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty;New Engl. J. Med,2012

4. Fibroblast-mediated drug resistance in cancer;Paraiso;Biochem. Pharmacol.,2013

5. FDA, U.S. Food and Drug Administration. Approved Drugs – Trametinib/Dabrafenib - http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm476837.htm.Acesso em. 12.12.2015.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual RNase activity of IRE1 as a target for anticancer therapies;Journal of Cell Communication and Signaling;2023-09-18

2. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells;Current Topics in Medicinal Chemistry;2023-04

3. New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways;Cancers;2022-11-26

4. Endoplasmic reticulum stress in melanoma pathogenesis and resistance;Biomedicine & Pharmacotherapy;2022-11

5. Redox-Related Proteins in Melanoma Progression;Antioxidants;2022-02-22